(Q51974873)

19 April 2018

title

Nicotinic modulation in an animal model of a form of associative learning impaired in Alzheimer's disease. (English)

1 reference

19 April 2018

author name string

Woodruff-Pak DS

series ordinal

1

1 reference

19 April 2018

Santos IS

series ordinal

2

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

19 April 2018

Behavioural Brain Research

published in

1 reference

19 April 2018

volume

113

1 reference

19 April 2018

issue

1-2

1 reference

19 April 2018

page(s)

11-19

1 reference

19 April 2018

The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Neuronal Substrate of Classical Conditioning in the Hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Single-unit analysis of different hippocampal cell types during classical conditioning of rabbit nictitating membrane response.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Neuronal plasticity in the limbic system during classical conditioning of the rabbit nictitating membrane response. I. The hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Classical eyeblink conditioning in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Disruption of classical conditioning in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Altered activity in the hippocampus is more detrimental to classical conditioning than removing the structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Mecamylamine- or scopolamine-induced learning impairment: ameliorated by nefiracetam.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Hippocampus in delay eyeblink classical conditioning: essential for nefiracetam amelioration of learning in older rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Eyeblink classical conditioning in Alzheimer's disease and cerebrovascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

The older rabbit as an animal model: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Disruption of human eyeblink conditioning after central cholinergic blockade with scopolamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Predictors of eyeblink classical conditioning over the adult age span.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

Nicotinic cholinergic system involvement in eyeblink classical conditioning in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900196-0

7 January 2021

10.1016/S0166-4328(00)00196-0

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018